MARTELLI, Maria Paola
MARTELLI, Maria Paola
DIPARTIMENTO DI MEDICINA E CHIRURGIA
A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml)
2021 Venanzi, A.; Rossi, R.; Martino, G.; Annibali, O.; Avvisati, G.; Mameli, M. G.; Sportoletti, P.; Tiacci, E.; Falini, B.; Martelli, M. P.
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
2009 Bolli, N.; De Marco, M.; Martelli, Maria Paola; Bigerna, B.; Pucciarini, A.; Rossi, R.; Mannucci, R.; Manes, N.; Pettirossi, V.; Pileri, S.; Nicoletti, Ildo; Falini, B.
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)
2008 Liso, A; Castiglione, F; Cappuccio, A; Stracci, Fabrizio; Schlenk, Rf; Amadori, S; Thiede, C; Schnittger, S; Valk, Pj; Döhner, K; Martelli, Massimo Fabrizio; Schaich, M; Krauter, J; Ganser, A; Martelli, Maria Paola; Bolli, N; Löwenberg, B; Haferlach, T; Ehninger, G; Mandelli, F; Döhner, H; Michor, F; Falini, Brunangelo
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure
2023 Sartor, C; Brunetti, L; Audisio, E; Cignetti, A; Zannoni, L; Cristiano, G; Nanni, J; Ciruolo, R; Zingarelli, F; Ottaviani, E; Patuelli, A; Bandini, L; Forte, D; Sciabolacci, S; Cardinali, V; Papayannidis, C; Cavo, M; Martelli, M P; Curti, A
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.
2008 Martelli, Maria Paola; Manes, N.; Liso, A.; Pettirossi, Valentina; Verducci Galletti, B.; Bigerna, B.; Pucciarini, A.; De Marco, M.; Pallotta, M.; Bolli, N.; Sborgia, M.; Di Raimondo, F.; Fabbiano, F.; Meloni, G.; Specchia, G.; Martelli, Massimo Fabrizio; Falini, B.
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML.
2006 Falini, Brunangelo; Bigerna, B; Pucciarini, A; Tiacci, Enrico; Mecucci, Cristina; Morris, Sw; Bolli, Niccolo'; Rosati, R; Hanissian, S; Ma, Z; Sun, Y; Colombo, E; Arber, Da; Pacini, R; LA STARZA, Roberta; Verducci Galletti, B; Liso, A; Martelli, Maria Paola; Diverio, D; Pelicci, Pg; Lo Coco, F; Martelli, Massimo Fabrizio
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia.
2012 Tiacci, Enrico; Pucciarini, A; Bigerna, B; Pettirossi, V; Strozzini, F; Martelli, Maria Paola; Tabarrini, A; Drexler, Hg; Falini, B.
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML.
2008 Martelli, Maria Paola; Manes, N; Pettirossi, V; Liso, A; Pacini, R; Mannucci, R; Zei, T; Bolli, Niccolo'; di Raimondo, F; Specchia, G; Nicoletti, Ildo; Martelli, Mf; Falini, Brunangelo
Absence of nucleophosmin leukemic mutants in B and T cells from AML with NPM1 mutations: Implications for the cell of origin of NPMC plus AML
2007 Martelli, Maria Paola; Manes, N; Pettirossi, V; Liso, A; Pacini, R; Mannucci, R; Zei, T; Bolli, N; Di Raimondo, F; Specchia, G; Nicoletti, I; Martelli, Mf; Falini, B.
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy
2021 Wu, H. -C.; Rerolle, D.; Berthier, C.; Hleihel, R.; Sakamoto, T.; Quentin, S.; Benhenda, S.; Morganti, C.; Wu, C.; Conte, L.; Rimsky, S.; Sebert, M.; Clappier, E.; Souquere, S.; Gachet, S.; Soulier, J.; Durand, S.; Trowbridge, J. J.; Benit, P.; Rustin, P.; Hajj, H. E.; Raffoux, E.; Ades, L.; Itzykson, R.; Dombret, H.; Fenaux, P.; Espeli, O.; Kroemer, G.; Brunetti, L.; Mak, T. W.; Lallemand-Breitenbach, V.; Bazarbachi, A.; Falini, B.; Ito, K.; Martelli, M. P.; de The, H.
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
2009 Falini, Brunangelo; Sportoletti, Paolo; Martelli, Maria Paola
Acute Myeloid Leukemia with mutated nucleophosmin (NPM1). Any hope for a targeted therapy?
2011 Falini, Brunangelo; Gionfriddo, I; Cecchetti, F; Ballanti, S; Pettirossi, Valentina; Martelli, Maria Paola
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
2011 Falini, Brunangelo; Martelli, Maria Paola; Bolli, Niccolo'; Sportoletti, Paolo; Liso, A; Tiacci, Enrico; Haferlach, T.
ADDITION OF THIOTEPA IMPROVES RESULTS IN T-CELL DEPLETED BONE-MARROW TRANSPLANT FOR ADVANCED LEUKEMIA
1993 Aversa, F; Terenzi, A; Carrotti, A; Martelli, Maria Paola; Latini, P; Gambelunghe, C; Martelli, Mf
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature
2016 Forghieri, Fabio; Bigliardi, Sara; Quadrelli, Chiara; Morselli, Monica; Potenza, Leonardo; Paolini, Ambra; Colaci, Elisabetta; Barozzi, Patrizia; Zucchini, Patrizia; Riva, Giovanni; Vallerini, Daniela; Lagreca, Ivana; Marasca, Roberto; Narni, Franco; Venditti, Adriano; Martelli, Maria Paola; Falini, Brunangelo; Lo Coco, Francesco; Amadori, Sergio; Luppi, Mario
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
2009 Falini, Brunangelo; Bolli, Niccolo'; Liso, Arcangelo; Martelli, Maria Paola; Mannucci, Roberta; Pileri, S.; Nicoletti, Ildo
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
2009 Haferlach, C.; Mecucci, Cristina; Schnittger, S.; Kohlmann, A.; Mancini, M.; Cuneo, A.; Testoni, N.; Rege Cambrin, G.; Santucci, A.; Vignetti, M.; Fazi, P.; Martelli, Maria Paola; Haferlach, T.; Falini, Brunangelo
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy.
2009 Falini, Brunangelo; Martelli, Maria Paola
ARPIR: automatic RNA-Seq pipelines with interactive report
2020 Spinozzi, G.; Tini, V.; Adorni, A.; Falini, B.; Martelli, M. P.
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells
2015 Martelli, Maria Paola; Gionfriddo, Ilaria; Mezzasoma, Federica; Milano, Francesca; Pierangeli, Sara; Mulas, Floriana; Pacini, Roberta; Tabarrini, Alessia; Pettirossi, Valentina; Rossi, Roberta; Vetro, Calogero; Brunetti, Lorenzo; Sportoletti, Paolo; Tiacci, Enrico; Di Raimondo, Francesco; Falini, Brunangelo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml) | 2021 | Venanzi, A.; Rossi, R.; Martino, G.; Annibali, O.; Avvisati, G.; Mameli, M. G.; Sportoletti, P.; Tiacci, E.; Falini, B.; Martelli, M. P. | |
| A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF. | 2009 | Bolli, N.; De Marco, M.; Martelli, Maria Paola; Bigerna, B.; Pucciarini, A.; Rossi, R.; Mannucci, R.; Manes, N.; Pettirossi, V.; Pileri, S.; Nicoletti, Ildo; Falini, B. | |
| A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) | 2008 | Liso, A; Castiglione, F; Cappuccio, A; Stracci, Fabrizio; Schlenk, Rf; Amadori, S; Thiede, C; Schnittger, S; Valk, Pj; Döhner, K; Martelli, Massimo Fabrizio; Schaich, M; Krauter, J; Ganser, A; Martelli, Maria Paola; Bolli, N; Löwenberg, B; Haferlach, T; Ehninger, G; Mandelli, F; Döhner, H; Michor, F; Falini, Brunangelo | |
| A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure | 2023 | Sartor, C; Brunetti, L; Audisio, E; Cignetti, A; Zannoni, L; Cristiano, G; Nanni, J; Ciruolo, R; Zingarelli, F; Ottaviani, E; Patuelli, A; Bandini, L; Forte, D; Sciabolacci, S; Cardinali, V; Papayannidis, C; Cavo, M; Martelli, M P; Curti, A | |
| A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. | 2008 | Martelli, Maria Paola; Manes, N.; Liso, A.; Pettirossi, Valentina; Verducci Galletti, B.; Bigerna, B.; Pucciarini, A.; De Marco, M.; Pallotta, M.; Bolli, N.; Sborgia, M.; Di Raimondo, F.; Fabbiano, F.; Meloni, G.; Specchia, G.; Martelli, Massimo Fabrizio; Falini, B. | |
| Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. | 2006 | Falini, Brunangelo; Bigerna, B; Pucciarini, A; Tiacci, Enrico; Mecucci, Cristina; Morris, Sw; Bolli, Niccolo'; Rosati, R; Hanissian, S; Ma, Z; Sun, Y; Colombo, E; Arber, Da; Pacini, R; LA STARZA, Roberta; Verducci Galletti, B; Liso, A; Martelli, Maria Paola; Diverio, D; Pelicci, Pg; Lo Coco, F; Martelli, Massimo Fabrizio | |
| Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia. | 2012 | Tiacci, Enrico; Pucciarini, A; Bigerna, B; Pettirossi, V; Strozzini, F; Martelli, Maria Paola; Tabarrini, A; Drexler, Hg; Falini, B. | |
| Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. | 2008 | Martelli, Maria Paola; Manes, N; Pettirossi, V; Liso, A; Pacini, R; Mannucci, R; Zei, T; Bolli, Niccolo'; di Raimondo, F; Specchia, G; Nicoletti, Ildo; Martelli, Mf; Falini, Brunangelo | |
| Absence of nucleophosmin leukemic mutants in B and T cells from AML with NPM1 mutations: Implications for the cell of origin of NPMC plus AML | 2007 | Martelli, Maria Paola; Manes, N; Pettirossi, V; Liso, A; Pacini, R; Mannucci, R; Zei, T; Bolli, N; Di Raimondo, F; Specchia, G; Nicoletti, I; Martelli, Mf; Falini, B. | |
| Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy | 2021 | Wu, H. -C.; Rerolle, D.; Berthier, C.; Hleihel, R.; Sakamoto, T.; Quentin, S.; Benhenda, S.; Morganti, C.; Wu, C.; Conte, L.; Rimsky, S.; Sebert, M.; Clappier, E.; Souquere, S.; Gachet, S.; Soulier, J.; Durand, S.; Trowbridge, J. J.; Benit, P.; Rustin, P.; Hajj, H. E.; Raffoux, E.; Ades, L.; Itzykson, R.; Dombret, H.; Fenaux, P.; Espeli, O.; Kroemer, G.; Brunetti, L.; Mak, T. W.; Lallemand-Breitenbach, V.; Bazarbachi, A.; Falini, B.; Ito, K.; Martelli, M. P.; de The, H. | |
| Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. | 2009 | Falini, Brunangelo; Sportoletti, Paolo; Martelli, Maria Paola | |
| Acute Myeloid Leukemia with mutated nucleophosmin (NPM1). Any hope for a targeted therapy? | 2011 | Falini, Brunangelo; Gionfriddo, I; Cecchetti, F; Ballanti, S; Pettirossi, Valentina; Martelli, Maria Paola | |
| Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? | 2011 | Falini, Brunangelo; Martelli, Maria Paola; Bolli, Niccolo'; Sportoletti, Paolo; Liso, A; Tiacci, Enrico; Haferlach, T. | |
| ADDITION OF THIOTEPA IMPROVES RESULTS IN T-CELL DEPLETED BONE-MARROW TRANSPLANT FOR ADVANCED LEUKEMIA | 1993 | Aversa, F; Terenzi, A; Carrotti, A; Martelli, Maria Paola; Latini, P; Gambelunghe, C; Martelli, Mf | |
| All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature | 2016 | Forghieri, Fabio; Bigliardi, Sara; Quadrelli, Chiara; Morselli, Monica; Potenza, Leonardo; Paolini, Ambra; Colaci, Elisabetta; Barozzi, Patrizia; Zucchini, Patrizia; Riva, Giovanni; Vallerini, Daniela; Lagreca, Ivana; Marasca, Roberto; Narni, Franco; Venditti, Adriano; Martelli, Maria Paola; Falini, Brunangelo; Lo Coco, Francesco; Amadori, Sergio; Luppi, Mario | |
| Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. | 2009 | Falini, Brunangelo; Bolli, Niccolo'; Liso, Arcangelo; Martelli, Maria Paola; Mannucci, Roberta; Pileri, S.; Nicoletti, Ildo | |
| AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features | 2009 | Haferlach, C.; Mecucci, Cristina; Schnittger, S.; Kohlmann, A.; Mancini, M.; Cuneo, A.; Testoni, N.; Rege Cambrin, G.; Santucci, A.; Vignetti, M.; Fazi, P.; Martelli, Maria Paola; Haferlach, T.; Falini, Brunangelo | |
| Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. | 2009 | Falini, Brunangelo; Martelli, Maria Paola | |
| ARPIR: automatic RNA-Seq pipelines with interactive report | 2020 | Spinozzi, G.; Tini, V.; Adorni, A.; Falini, B.; Martelli, M. P. | |
| Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells | 2015 | Martelli, Maria Paola; Gionfriddo, Ilaria; Mezzasoma, Federica; Milano, Francesca; Pierangeli, Sara; Mulas, Floriana; Pacini, Roberta; Tabarrini, Alessia; Pettirossi, Valentina; Rossi, Roberta; Vetro, Calogero; Brunetti, Lorenzo; Sportoletti, Paolo; Tiacci, Enrico; Di Raimondo, Francesco; Falini, Brunangelo |